Assessment of Use of Combined Dextromethorphan and Quinidine in Patients With Dementia or Parkinson Disease After US Food and Drug Administration Approval for Pseudobulbar Affect.
Fralick, Michael MD; SM 1,2; Sacks, Chana A. MD; MPH 1; Kesselheim, Aaron S. MD; JD; MPH 1
JAMA Internal Medicine.
179(2):224-230, February 2019.
(Format: HTML, PDF)